维普期刊资源整合服务平台（V6.5）

173篇 您的检索式：作者名="Germing U"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Prospective validation of the WHO proposals for the classification of myelodysplastic syn- dromes显示文摘	Germing U Strupp C KuendgenA	2006	Hematologica2006，91，12：	1
2	The myelodysplastic/myeloprolifera- tire neoplasms:myeloproliferative diseases with dysplastic features 显示文摘	Orazi A Germing U	2008	Leukemia2008，22，7：	1
3	Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 显示文摘	MALCOVATI L GERMING U KUENDGEN A	2007	Clin Oncol2007，25，：	1
4	Secondary myelodysplastic syndrome after fludarabine therapy of a low - grade non - Hodgkin's lymphoma显示文摘	Misgeld E Germing U Aul C	2001	Leuk Res2001，25，1：	1
5	Angioimmunoblastic lymphadenopathy(AILD) mayrespond to thalidomidle treatment:Two case reports显示文摘	Strupp C Aivado M Germing U	2002	Leuk Lymphoma2002，43，1：	1
6	Thalidomide for the treatment of patients with myelodysplastic syndromes显示文摘	Strupp C Germing U Aivado M	2002	Leukemia2002，16，1：	1
7	The myelodysplastic/myeloprolifera- tive neoplasms:myeloproliferative diseases with dysplas- tic features显示文摘	Orazi A Germing U	2008	Leukemia2008，22，7：	1
8	Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes显示文摘	Malcovati L Germing U Kuendgen A		0，，23：	1
9	Loe IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antitymocyte globulin显示文摘	LIM Z Y KILLICK S GERMING U	2007	Leukemia2007，21，：	1
10	New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:evidence from a core dataset of 2124 patients显示文摘	Haase D Germing U Sehanz J	2007	Blood2007，110，13：	1
11	New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 pa- tients 显示文摘	Haase D Germing U Schanz J	2007	Blood2007，110，13：	1
12	Differences in epidemiology of MDS between Western and Eastern countries:Ethnic differences or environmental influence 显示文摘	Kuendgen A Matsuda A Germing U	2007	Leuk Res2007，31，1：	1
13	No increase in age- specific incidence of myelodysplastic syndromes 显示文摘	Germing U Strupp C Kfindgen A	2004	Haematologica2004，89，8：	1
14	Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)显示文摘	Germing U Hildebrandt B Pfeilst6cker M	2005	Leukemia2005，19，12：	1
15	Low IPSS score and bone mar- row hypocellularity in MDS patients predict hematological responses to antithymocyte globulin 显示文摘	Lim ZY Killick S Germing U	2007	Leukemia2007，21，7：	1
16	Thalidomide for the treatment ofmyelodysplastic syndromes显示文摘	STRUPP C GERMING U HILDEBRANDT B	2002	Leuk Res2002，27，1：	1
17	Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Dusseldorf registry on myelodysplastic syndromes显示文摘	Germing U Strupp C Giagounidis A	2012	Leuk Res2012，36，6：	1
18	Refractory anaemia with excess of blasts ( RAEB ) : analysis of reclassification according to the WHO proposals 显示文摘	Germing U Strupp C Kuendgen A	2006	Br J Haematol2006，132，：	1
19	New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:evidence from a core dataset of 2124显示文摘	HAASE D GERMING U SCHANZ J	2007	Blood2007，110，13：	1
20	New insights into the prog- nostic impact of the karyotype in MDS and correlation with sub- types~evidence from a core dataset of 2124 patients显示文摘	H aase D Germing U Schanz J	2007	Blood2007，110，13：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示